Role of nonresolving inflammation in hepatocellular carcinoma development and progression
LX Yu, Y Ling, HY Wang - NPJ precision oncology, 2018 - nature.com
Hepatocellular carcinoma (HCC) has become a leading cause of cancer-related death,
making the elucidation of its underlying mechanisms an urgent priority. Inflammation is an …
making the elucidation of its underlying mechanisms an urgent priority. Inflammation is an …
MicroRNAs in the pathogenesis of hepatocellular carcinoma: A review
A Morishita, K Oura, T Tadokoro, K Fujita, J Tani… - Cancers, 2021 - mdpi.com
Simple Summary Hepatocellular carcinoma (HCC) is one of the most frequently occurring
cancers, and the prognosis for late-stage HCC remains poor. A better understanding of the …
cancers, and the prognosis for late-stage HCC remains poor. A better understanding of the …
The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer
X Zheng, M Huang, L **ng, R Yang, X Wang, R Jiang… - Molecular cancer, 2020 - Springer
Background Increasing studies have shown that circRNA is closely related to the
carcinogenesis and development of many cancers. However, biological functions and the …
carcinogenesis and development of many cancers. However, biological functions and the …
Tumor-derived exosomal circPSMA1 facilitates the tumorigenesis, metastasis, and migration in triple-negative breast cancer (TNBC) through miR-637/Akt1/β-catenin …
S Yang, D Wang, S Zhong, W Chen, F Wang… - Cell death & …, 2021 - nature.com
Circular RNAs (circRNAs) are increasingly gaining importance and attention due to their
diverse potential functions and their value as diagnostic biomarkers (disease specific). This …
diverse potential functions and their value as diagnostic biomarkers (disease specific). This …
MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma
F Fang, R Chang, L Yu, X Lei, S **ao, H Yang… - Journal of …, 2015 - Elsevier
Background & Aims Hepatocellular carcinoma (HCC) is one of the most common
malignancies worldwide. However, the detailed molecular mechanisms underlying HCC …
malignancies worldwide. However, the detailed molecular mechanisms underlying HCC …
circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637
Y Zhang, C Li, X Liu, Y Wang, R Zhao, Y Yang… - …, 2019 - thelancet.com
Background Resistance to oxaliplatin-based chemotherapy is a major cause of recurrence
in colorectal cancer (CRC) patients. There is increasing evidence indicating that circHIPK3 …
in colorectal cancer (CRC) patients. There is increasing evidence indicating that circHIPK3 …
Jak-stat signaling induced by interleukin-6 family cytokines in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. It
can be caused by chronic liver cell injury with resulting sustained inflammation, eg, triggered …
can be caused by chronic liver cell injury with resulting sustained inflammation, eg, triggered …
Hotair mediates hepatocarcinogenesis through suppressing miRNA-218 expression and activating P14 and P16 signaling
Background & Aims Long non-coding RNA Hotair has been considered as a pro-oncogene
in multiple cancers. Although there is emerging evidence that reveals its biological function …
in multiple cancers. Although there is emerging evidence that reveals its biological function …
[HTML][HTML] STAT proteins–key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver
Since its discovery in the early 1990s, the Janus kinase (JAK)-signal transducer and
activator of transcription (STAT) signaling pathway has been found to play key roles in …
activator of transcription (STAT) signaling pathway has been found to play key roles in …
Exploring the JAK/STAT signaling pathway in hepatocellular carcinoma: unraveling signaling complexity and therapeutic implications
H Park, S Lee, J Lee, H Moon, SW Ro - International Journal of Molecular …, 2023 - mdpi.com
Hepatocellular Carcinoma (HCC) continues to pose a substantial global health challenge
due to its high incidence and limited therapeutic options. In recent years, the Janus Kinase …
due to its high incidence and limited therapeutic options. In recent years, the Janus Kinase …